172 related articles for article (PubMed ID: 10702891)
1. Interaction potential and tolerability of the coadministration of cilostazol and aspirin.
Mallikaarjun S; Forbes WP; Bramer SL
Clin Pharmacokinet; 1999; 37 Suppl 2():87-93. PubMed ID: 10702891
[TBL] [Abstract][Full Text] [Related]
2. Effect of cilostazol on the pharmacokinetics and pharmacodynamics of warfarin.
Mallikaarjun S; Bramer SL
Clin Pharmacokinet; 1999; 37 Suppl 2():79-86. PubMed ID: 10702890
[TBL] [Abstract][Full Text] [Related]
3. Effect of multiple cilostazol doses on single dose lovastatin pharmacokinetics in healthy volunteers.
Bramer SL; Brisson J; Corey AE; Mallikaarjun S
Clin Pharmacokinet; 1999; 37 Suppl 2():69-77. PubMed ID: 10702889
[TBL] [Abstract][Full Text] [Related]
4. Effects of CYP3A inhibition on the metabolism of cilostazol.
Suri A; Forbes WP; Bramer SL
Clin Pharmacokinet; 1999; 37 Suppl 2():61-8. PubMed ID: 10702888
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease.
Bramer SL; Forbes WP; Mallikaarjun S
Clin Pharmacokinet; 1999; 37 Suppl 2():1-11. PubMed ID: 10702882
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.
Bramer SL; Suri A
Clin Pharmacokinet; 1999; 37 Suppl 2():41-51. PubMed ID: 10702886
[TBL] [Abstract][Full Text] [Related]
7. Effect of omeprazole on the metabolism of cilostazol.
Suri A; Bramer SL
Clin Pharmacokinet; 1999; 37 Suppl 2():53-9. PubMed ID: 10702887
[TBL] [Abstract][Full Text] [Related]
8. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
Bramer SL; Forbes WP
Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
[TBL] [Abstract][Full Text] [Related]
9. No clinically relevant interaction between sugammadex and aspirin on platelet aggregation and coagulation parameters.
de Kam PJ; El Galta R; Kruithof AC; Fennema H; van Lierop MJ; Mihara K; Burggraaf J; Moerland M; Peeters P; Troyer MD
Int J Clin Pharmacol Ther; 2013 Dec; 51(12):976-85. PubMed ID: 24120718
[TBL] [Abstract][Full Text] [Related]
10. Combined aspirin and cilostazol treatment is associated with reduced platelet aggregation and prevention of exercise-induced platelet activation.
Cleanthis M; Bhattacharya V; Smout J; Ashour H; Stansby G
Eur J Vasc Endovasc Surg; 2009 May; 37(5):604-10. PubMed ID: 19297212
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic modeling of the antiplatelet and cardiovascular effects of cilostazol in healthy humans.
Woo SK; Kang WK; Kwon KI
Clin Pharmacol Ther; 2002 Apr; 71(4):246-52. PubMed ID: 11956507
[TBL] [Abstract][Full Text] [Related]
12. Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers.
Ollier C; Faaij RA; Santoni A; Duvauchelle T; van Haard PM; Schoemaker RC; Cohen AF; de Greef R; Burggraaf J
Clin Pharmacokinet; 2002; 41 Suppl 2():31-7. PubMed ID: 12383043
[TBL] [Abstract][Full Text] [Related]
13. The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects.
Kim HS; Kim GY; Yeo CW; Oh M; Ghim JL; Shon JH; Kim EY; Kim DH; Shin JG
Br J Clin Pharmacol; 2014 May; 77(5):821-30. PubMed ID: 24001154
[TBL] [Abstract][Full Text] [Related]
14. Potential interactions between cilostazol and probucol: a two-part, single-dose, open-label study in healthy Korean male volunteers.
Kim KP; Kim BH; Lim KS; Kim TE; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Oct; 31(10):2098-106. PubMed ID: 19922880
[TBL] [Abstract][Full Text] [Related]
15. A randomized crossover comparative study of aspirin, cilostazol and clopidogrel in normal controls: analysis with quantitative bleeding time and platelet aggregation test.
Kim JS; Lee KS; Kim YI; Tamai Y; Nakahata R; Takami H
J Clin Neurosci; 2004 Aug; 11(6):600-2. PubMed ID: 15261228
[TBL] [Abstract][Full Text] [Related]
16. Effect of renal impairment on the pharmacokinetics of cilostazol and its metabolites.
Mallikaarjun S; Forbes WP; Bramer SL
Clin Pharmacokinet; 1999; 37 Suppl 2():33-40. PubMed ID: 10702885
[TBL] [Abstract][Full Text] [Related]
17. Effect of cilostazol on platelet aggregation and experimental thrombosis.
Kimura Y; Tani T; Kanbe T; Watanabe K
Arzneimittelforschung; 1985; 35(7A):1144-9. PubMed ID: 4074426
[TBL] [Abstract][Full Text] [Related]
18. Cilostazol.
Sorkin EM; Markham A
Drugs Aging; 1999 Jan; 14(1):63-71; discussion 72-3. PubMed ID: 10069409
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol: a review of its use in intermittent claudication.
Chapman TM; Goa KL
Am J Cardiovasc Drugs; 2003; 3(2):117-38. PubMed ID: 14727939
[TBL] [Abstract][Full Text] [Related]
20. The effect of nimesulide versus placebo on hemostasis in healthy volunteers.
Marbet GA; Yasikoff Strub ML; Macciocchi A; Tsakiris DA
Eur J Clin Pharmacol; 1998 Jul; 54(5):383-7. PubMed ID: 9754980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
